Science Daily reports in its 15 August edition that the active ingredient in an over-the-counter skin cream might slow or stop the effects of Parkinson’s disease on brain cells. Scientists at the University of California identified the link through biochemical and cellular studies, but the research team is now testing the drug, known as kinetin, in animal models of Parkinson’s. The research is published in the August 15, 2013 issue of the journal Cell. Kevan Shokat of the University of California, San Francisco, is quoted as saying “Kinetin is a great molecule to pursue because it’s already sold in drugstores as a topical anti-wrinkle cream, So it’s a drug we know has been in people and is safe.”